StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock.
Navidea Biopharmaceuticals Stock Performance
Shares of Navidea Biopharmaceuticals stock opened at $0.00 on Wednesday. Navidea Biopharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.13.
Navidea Biopharmaceuticals Company Profile
Further Reading
- Five stocks we like better than Navidea Biopharmaceuticals
- How to Use the MarketBeat Excel Dividend Calculator
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Stock Dividend Cuts Happen Are You Ready?
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.